News on technologies and applications for point-of-care testing.
Amarantus has reacquired LymPro Test, MSPrecise, and NuroPro and said that it plans to assign the assets to a new subsidiary.
Through its large network of ambulatory labs, the university's pathology and lab medicine department is evaluating a BioFire rapid diagnostic test for the flu.
The molecular test can provide results in 30 minutes from nasal swabs on a palm-sized instrument.
The quantitative paper-based DNA reader (qPDR) takes advantage of a recently discovered interaction between SYBR Green I and cellulose paper.
Abbott's CFO said he expects mid-single-digit growth from diagnostics in Q1 2018 and mid-to-high single digit growth for the full year.
